The Future of Mental Health Management

The Future of Mental Health Management

An Innovation Culture in Mental Health Management Complements Current Therapies for Improved Efficacy and Access to Care

RELEASE DATE
22-Jun-2023
REGION
Global
Research Code: DAA7-01-00-00-00
SKU: HC03677-GL-TR_27804
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC03677-GL-TR_27804
$4,950.00
DownloadLink
ENQUIRE NOW

Description

Mental health conditions reduce people’s life expectancy—yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments emerge that can complement existing therapies for better outcomes.

Treating mental health issues is challenging because a condition may have varying causes, such as environmental and genetic factors, and different symptoms present themselves in different degrees. As a result, combining therapies—instead of using a single therapy—could result in better efficacy. Psychotherapy and medication have been long-standing treatment methods, and now more advanced techniques for diagnosis and treatment can prove beneficial for people with limited access to a clinic, like telehealth consultations or the use of virtual reality, artificial intelligence/machine learning, and the use of wearables for detecting a symptom and notifying a medical professional. These advanced technologies help serve patients throughout the day and not just during emergencies, which closes the gaps in care. Research is also underway for biomarkers and other diagnostic tools that can detect a mental health condition, surpassing the traditional technique of monitoring symptoms for a certain period.

Much development is also undergoing in the nootropic space. Nootropics, generally used to improve brain performance, are available without a medical prescription. Microbiome therapeutics and naturally available substances are another area being explored further for therapeutic benefits.

This Frost & Sullivan report identifies the challenges, drivers, and growth opportunities in this space and helps foresee its growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. Finally, the report provides a detailed account of the funding landscape for stakeholders and market players to leverage.

Table of Contents

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Mental Health Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Research Context and Scope of Analysis

Segmentation

Other Techniques for Mental Health Management

Growth Drivers

Growth Restraints

Introduction

The Impact of the COVID-19 Pandemic on Mental Health

Roadblocks to the Mental Health Industry’s Development

An Introduction to Mental Health Conditions

Treatment Approaches to Mental Health

Drug-based Therapeutic Intervention in Mental Health

Drug-based Therapeutic Intervention Intervention in Mental Health (continued)

Drug-based Therapeutic Intervention in Mental Health (continued)

Drug-based Therapeutic Intervention in Mental Health (continued)

Drug-based Therapeutic Intervention in Mental Health (continued)

Therapeutic Intervention in Mental Health (continued)

Therapeutic Intervention in Mental Health (continued)

Therapeutic Intervention in Mental Health (continued)

A Snapshot of Schizophrenia Research

A Snapshot of Anxiety Research

A Snapshot of Depression Research

A Snapshot of BD Research

A Snapshot of Eating Disorder, Sleeping Disorder, PTSD, and Substance Use Research

Upcoming Innovations in the Field of Mental Health

Brain Boosting Nutraceuticals/Nootropics

Telehealth Services to Cater to All Age Groups

Self-help, Meditation, and Mindfulness Mobile Applications

Virtual Reality, AI and Machine Learning for Mental Health Management

Diagnostics and Biomarker Development for Mental Health Conditions

Innovation Ecosystem Summary

The Mental Health Landscape in Europe and the United States

The Mental Health Landscape in Select Asia-Pacific (APAC) Countries

The Mental Health Landscape in Select APAC Countries and the Middle East

The Mental Health Landscape in Other Select Countries

The Patent Landscape for Mental Health

The Patent Landscape for Mental Health (continued)

Key Takeaways from the IP Filing Analysis

Strategic Partnerships Between Mental Health-focused Companies

Funding Ecosystem

Funding Ecosystem (continued)

Mergers and Acquisitions in Mental Health Industry

Key Takeaways from the Stakeholder Ecosystem

Growth Opportunity 1: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes in Mental Health Management

Growth Opportunity 1: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes in Mental Health Management (continued)

Growth Opportunity 2: The Development of Targeted Prescription Treatments

Growth Opportunity 2: The Development of Targeted Prescription Treatments (continued)

Growth Opportunity 3: Benchmarking Mental Health Applications Based on Efficacy Evidence

Growth Opportunity 3: Benchmarking Mental Health Applications Based on Efficacy Evidence (continued)

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer

Mental health conditions reduce people’s life expectancy—yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments emerge that can complement existing therapies for better outcomes. Treating mental health issues is challenging because a condition may have varying causes, such as environmental and genetic factors, and different symptoms present themselves in different degrees. As a result, combining therapies—instead of using a single therapy—could result in better efficacy. Psychotherapy and medication have been long-standing treatment methods, and now more advanced techniques for diagnosis and treatment can prove beneficial for people with limited access to a clinic, like telehealth consultations or the use of virtual reality, artificial intelligence/machine learning, and the use of wearables for detecting a symptom and notifying a medical professional. These advanced technologies help serve patients throughout the day and not just during emergencies, which closes the gaps in care. Research is also underway for biomarkers and other diagnostic tools that can detect a mental health condition, surpassing the traditional technique of monitoring symptoms for a certain period. Much development is also undergoing in the nootropic space. Nootropics, generally used to improve brain performance, are available without a medical prescription. Microbiome therapeutics and naturally available substances are another area being explored further for therapeutic benefits. This Frost & Sullivan report identifies the challenges, drivers, and growth opportunities in this space and helps foresee its growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. Finally, the report provides a detailed account of the funding landscape for stakeholders and market players to leverage.
More Information
Author Lonita lawrence
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 mental health management
Keyword 2 future of mental health technology
Keyword 3 mental health services
Podcast No
WIP Number DAA7-01-00-00-00